An effort has been made to confirm the report [Dubinin, N. P. & Altukhov, Y. P. (1979) Proc. Natl. Acad. Sci. USA 76,[5226][5227][5228][5229]] that children born prematurely or exhibiting congenital defects can be shown to exhibit relatively high frequencies of rare (nonpolymorphic) electrophoretic variants of proteins and that a large proportion of these variants are due to mutation in either the father or the mother. In a series of 178 children who were comparable with those described in the earlier report, we failed to encounter a high frequency of these variants in some 5341 determinations involving 45 proteins, nor were any mutations observed. Data from 1583 determinations of enzyme activity on a subset of the panel of proteins were also unremarkable. We are thus unable to confirm the earlier report.
Acad. Sci. USA 76, 5226-5229] that children born prematurely or exhibiting congenital defects can be shown to exhibit relatively high frequencies of rare (nonpolymorphic) electrophoretic variants of proteins and that a large proportion of these variants are due to mutation in either the father or the mother. In a series of 178 children who were comparable with those described in the earlier report, we failed to encounter a high frequency of these variants in some 5341 determinations involving 45 proteins, nor were any mutations observed. Data from 1583 determinations of enzyme activity on a subset of the panel of proteins were also unremarkable. We are thus unable to confirm the earlier report.
In 1979, following several similar reports in Russian language journals, Dubinin and Altukhov (1) published in these PROCEEDINGS a communication reporting a high frequency of mutations affecting proteins among a selected infant populatioh. The abstract reads as follows:
Twelve proteins of enzymic and nonenzymic nature in blood samples of infants that deviate from the average population in physical development (50 premature and 177 fullterm infants with rough and multiple developmental defects) were studied by electrophoresis in polyacrylamide and starch gels. The control group consisted of 500 normal newborns. In infants with developmental disorders, the frequency of rare electrophoretic protein variants was found to be about one order of magnitude higher than in the control. It has been shown for at least five cases that such variants are de novo mutations. According to these data the mutation rate is -2 x 10 3 per locus per generation for the group selected and -6 x 10-5 for the total population. Despite the fact that further specification of the estimations found is required, we consider the results obtained as evidence in favor of the efficiency of the earlier substantiated monitoring model of gene mutations in the human population.. . This approach, which infers electrophoretic screening of blood proteins in a specially selected group of newborns, makes it possible to reduce the size of samples needed for statistically reliable estimations of the alteration of mutation rate.
The far-reaching implications of this report for the study of mutation are clear. It implies, inter alia, as the authors pointed out, that a search for biochemical mutations among the predominantly normal children born to a cohort subjected to some mutagenic exposure, such as the survivors of the atomic bombings, is a largely misplaced effort. In addition, there is a second, no less far reaching, implication, not stressed by the authors. Assume the report is correct, that there was a parental mutation rate of approximately 2 x 10-3 at the loci responsible for the 12 proteins sampled in a group of 227 defective infants. Since there was no preselection of the loci responsible for these 12 proteins on the basis of mutability, these loci were presumably neither more nor less mutable in this setting than the loci responsible for the thousands of other proteins that make up the human body. To a first approximation it follows that, if the battery of proteins studied could be expanded to several thousand, then each defective child would harbor several such mutations. Normal children, on the face of these findings, would be very much less likely to harbor such mutations. It would be difficult to escape the inference that mutations of this type played a primary role in the genesis of congenital defect and/or prematurity, an inference with no less startling implications for human development and teratogenesis than for the subject of genetic monitoring. Inasmuch as there was already in place in our laboratory a program examining consecutive newborn infants for the occurrence of mutations influencing electrophoretic mobility or enzyme activity (2, 3), we deemed it worthwhile, as an extension of this study, to attempt to repeat the abovedescribed observations.
PROTOCOL
The subjects of this study were drawn from three sources. The first source (the Pediatric Referral Series) was 169  168  168  169  169  166  165  169  169  166  166  124  168  168  168  34  35  19  19  13  19  17  19  13  47 trum in severity and uncertainty of diagnosis in the newborn.
Our original protocol was designed to exclude malformed children found to have karyotypic abnormalities, on the grounds that a sufficient cause for their defect has been established. When, however, an abstract appeared in 1982 (5) that we interpreted as reporting that 38% of the children in the Russian series had demonstrable karyotypic abnormalities (predominantly trisomy 21), a third group of children (the Karyotypic Series) was added to the protocol. These were all children with a variety of physical abnormalities referred to the Pediatric Cytogenetic Unit for diagnostic studies. Those children among these referrals who were not found to have chromosomal abnormalities but who did have major physical abnormalities have been combined for presentation with the defective children making up the first two series. Likewise, children in the first two series found in the course of their diagnostic work-up to have karyotypic abnormality are presented with the children in the Karyotypic Series. These three groups form the Study Series of Table 3 .
The control values for this study are based on studies of the normal infants in the previously described Cord Blood Series. These control frequencies were obtained concurrently with the determinations on the children with various defects.
The Russian investigators have never described in any detail the composition of their sample, but we have the impression that the severity of the defect in the children was such that they required institutionalization. In an effort to obtain a sample of children with a high degree of handicap, we have made a particular effort in our Congenital Defect Series to obtain samples from children with major cardiac or central nervous system abnormalities and also, as noted above, added a group of children with karyotypic abnormalities.
LABORATORY PROCEDURES Table 1 lists the plasma and erythrocyte proteins examined for electrophoretic variants, and Table 2 lists the subset of these proteins that, as enzymes, were examined for activity levels. For the purposes of these studies, heterozygosity for an enzyme deficiency variant is defined by an activity level -66% of normal. The rationale for this definition has been developed in detail elsewhere (6, 7) . Variants detected by this criterion will for the most part be the result of alleles whose gene product (if any) has no enzymatic activity (7, 8) or is very unstable. Descriptions of the techniques employed in this laboratory for the detection of both kinds of variants will be found in publications of Neel and co-workers (4, 9), Fielek and Mohrenweiser (10) , and Mohrenweiser and Fielek (11) . Whenever a variant other than one corresponding to a common genetic polymorphism was encountered, the samples obtained from the father and mother were examined, to determine whether the variant was inherited or had arisen within the last generation in consequence of a mutation. For convenience we term such variants "rare" variants. Failure to do family studies when a common, polymorphic variant is encountered carries the risk of missing some mutations that mimic common polymorphisms, but we have shown that this is a minor source of bias (9) . The protocol allowed for highresolution cytogenetic studies of any child exhibiting an apparent mutation but, as we shall see, the need for such studies did not arise. Table 3 lists the types of children included in the study. All children with karyotypic abnormalities exhibited major phenotypic findings, and they could be considered as a subset of children with congenital defects. On the other hand, the premature infants did not exhibit gross defects and, in fact, for the most part were ultimately discharged from the hospital as normal healthy infants. Most of these children have undergone extensive medical studies. Of the total of 178 children, 31 entered the series because of prematurity, 27 because of chromosomal abnormality associated with physical defects, and 120 because of a variety of congenital defects not known to be associated with a chromosomal abnormality.
FINDINGS
The electrophoretic findings in both the Study Series and the Control Series are summarized in Table 1 . Differing numbers of determinations per protein result from the introduction of new systems into the laboratory battery over the 3 years that the data have been accumulated, as well as the fact that some proteins cannot be typed with accuracy in newborn infants (e.g., haptoglobin and carbonic anhydrases I and II). In a total of 5341 determinations in the Study Series, there were 15 classified as exhibiting heterozygosity for a rare variant. All of these variants were present in one parent or the other and so were presumably inherited.
The findings with reference to activity variants are summarized in Table 2 . There were in the Study Series only two determinations characterized by approximately half-normal levels, among a total of 1583 determinations. These variants, of triosephosphate isomerase and glucose-6-phosphate dehydrogenase were observed in the same Black child. As has been previously described (11) , these variants occur as polymorphisms among the American Black populations (although they do not attain polymorphic proportions in this ethnically admixed series). The triosephosphate isomerase variant was inherited from the father and the glucose-6-phosphate dehydrogenase from the mother.
DISCUSSION
Dubinin and Altukhov (1) reported that rare (i.e., ndnpolymorphic) electrophoretic variants were encountered in 5 of 5085 determinations (10,170 locus tests) in their control-series, from which they calculate a frequency of 0.00031 ± 0.00014 per locus per individual, and in 15 of 2357 determinations (4714 locus tests) involving children with congenital defects/prematurity, from which they calculate an average frequency of 0.00203 ± 0.00052 per locus tested. (We cannot reproduce this calculation.) In the present series of control children, 236 rare variants were encountered in 108,963 determinations (215,609 locus tests), a frequency of 0.00109 + 0.00007 per locus tested (ref. 4 and unpublished data). In the series of children who were premature or were found to have major congenital defects, rare electrophoretic variants were encountered in 15 of 5341 determinations (10,603 locus tests), a frequency of 0.00141 per locus tested, with 95% confidence intervals of 0.00079 and 0.00233. We are thus unable to confirm the finding of an excess of rare variants in children with severe congenital defects and/or prematurity.
We have also failed to detect any mutations resulting in an electrophoretic variant in the aforementioned material, nor have we encountered any mutations resulting in a loss of enzyme activity in this series. By contrast, the Russian investigators reported that in all five instances in which they were able to do family studies on the parents of a defective child exhibiting a variant (among 14 such children), in no case did *These defects were as follows: (1) two myelomeningocoele with renal defect; (2) clinodactyly, syndactyly, ptosis, brittle hair, mild mental retardation, and unusual facies; (3) congenital glomerulonephritis, multiple epiphyseal dysplasia, and congenital deformed ear; (4) tetralogy of Fallot and atresia and stenosis of small intestine; (5) atrial and ventricuiar septal defect, pulmonic valvular stenosis, cleft palate, and Wilms tumor; (6) imperforate anus and absent right auditory canal; (7) spina bifida, aortic stenosis, and severe scoliosis; (8) absent left kidney and Hirschsprung disease; (9) rectovaginal fistula, sacral and vertebral anomalies, and bilateral pes equinovarus; (10) congenital mitral regurgitation and malrotation of bowel with volvulus; (11) holoprosencephaly, hypoteleorism, hypoplastic nose, multiple facial skin tags, low-set ears, choanal atresia, ventricular septal defect, anomalous venous return to heart, and left renal agenesis; (12) interventricular septal defect, micrognathia, pes equinovarus, and undescended testes; (13) first and second branchial arch syndrome, brachycephaly, plagiocephaly, and micrognathia; (14) gastroschisis and jejunal atresia; (15) double aortic arch, multiple abnormalities of vertebral and thoracic skeleton, and bilateral inguinal hernia; (16) congenital aortic regurgitation and Wilms tumor; (17) right porencephalic cyst, bilateral choreoretinal and optic nerve colobomas, hypoplastic thoracic vertebrae, and hemivertebra; (18) interventricular septal defect, abnormal sacral vertebrae, clinodactyly, dysplastic nails, congenital dislocation of hip, and failure to thrive.
either the father or the mother exhibit a similar variant. Limited "paternity exclusion" studies failed to reveal any evidence of a discrepancy between legal and biological parentage, so that the variants were presumed to result from a mutational event in one or the other parent. It is difficult to extract a mutation rate from these data for this general population. If we accept the authors' estimate of =2 x 10-per locus per generation, then the expectation in our series would be for more than 20 variants arising from mutation to have been detected. Clearly there is an enormous discrepancy.
It should be pointed out that even had the report proven Proc. NatL Acad ScL USA 81 (1984) Genetics: Neel and Mohrenweiser correct, this demonstration would not have simplified genetic monitoring to the extent implied by the authors. Numerators without denominators are of little value in genetic epidemiology. It would still be necessary to define the absolute frequency of defective children in a carefully defined study population, and, indeed, given the cause-and-effect relationship of biochemical mutation and congenital defect implied by the Russian studies, if the finding were correct then in most settings it would be more efficient simply to monitor the frequency of defective children.
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